Simon Ekman

Professor, Senior Consultant

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Simon Ekman is a faculty member at Karolinska University Hospital in Sweden. His research primarily focuses on lung cancer, specifically in areas such as prognostic indices for brain metastases, gene expression in non-small-cell lung cancer, and the impact of novel cancer therapies. He has authored several recent articles addressing trends in lung cancer survival and complications arising from innovative treatments. Professor Ekman's work contributes significantly to the understanding and management of cancer and its systemic effects.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Jan Linnros

KTH Royal Institute of Technology

SWEDEN

View details

Johan Botling

Associate professor

Uppsala University

SWEDEN

View details

Kenbugul Jatta

Karolinska University Hospital

SWEDEN

View details

Hildur Helgadottir

Karolinska Institutet

SWEDEN

View details

Konstantinos Rounis

Karolinska University Hospital

SWEDEN

View details

Patrick Micke

Professor

Uppsala University

SWEDEN

View details

Anni Virtanen

University of Helsinki

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simon Ekman

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases

NTRK Gene Expression in Non-Small-Cell Lung Cancer

Trends in lung cancer survival in the Nordic countries 1990–2016

Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors

Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Complications following novel therapies for non‐small cell lung cancer

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer

Multiplexed electrokinetic sensor for detection and therapy monitoring of extracellular vesicles from liquid biopsies of non-small-cell lung cancer patients

Programmed Cell Death Ligand 1 Expression in Resected Non–Small Cell Lung Cancer

Epidemiology and Survival Outcomes for Patients With NSCLC in Scandinavia in the Preimmunotherapy Era: A SCAN-LEAF Retrospective Analysis From the I-O Optimise Initiative

Collaborators (7)

Jan Linnros

Johan Botling

Kenbugul Jatta

Hildur Helgadottir

Konstantinos Rounis

Patrick Micke

Anni Virtanen

Make your next move.